Accendra Health Shareholders Approve Amended Omnibus Incentive Plan

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Accendra Health ( (ACH) ) has provided an update. At its May 14, 2026 Annual Meeting of Shareholders, Accendra Health, Inc. reported that investors approved an Amended and Restated 2023 Omnibus Incentive Plan, replacing the prior Owens & Minor, Inc. 2023 plan and empowering the Board’s People & Culture Committee to issue equity and other incentive awards to employees, non-employee directors, and consultants under individualized award agreements. Shareholders also elected six directors to one-year terms, ratified KPMG LLP as independent auditor for the 2026 fiscal year, and endorsed, on an advisory basis, the compensation of named executive officers, signaling broad investor support for the company’s leadership, compensation framework, and refreshed long-term incentive structure. The most recent analyst rating on (ACH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Accendra Health stock, see the ACH Stock Forecast page. Spark’s Take on ACH Stock According to Spark, TipRanks’ AI Analyst, ACH is a Neutral. The score is held down primarily by weak financial performance (sharp revenue contraction, large losses, negative equity, and negative recent free cash flow). The earnings call provides some offset via affirmed 2026 outlook, liquidity, and a pending balance-sheet optimization that extends maturities and could reduce leverage, but higher expected interest expense and recent cash-flow pressure remain key constraints. Technicals are mixed and do not provide a strong momentum tailwind, while valuation is challenged by ongoing losses and no dividend support. To see Spark’s full report on ACH stock, click here. More about Accendra Health Accendra Health, Inc., formerly operating under the Owens & Minor, Inc. incentive plan framework, is a healthcare-focused company that utilizes equity and other incentive awards to attract and retain employees, non-employee directors, and consultants. The company’s governance structure includes a Board-level People & Culture Committee responsible for administering its omnibus incentive plans to align stakeholder and management interests. Average Trading Volume: 885,851 Technical Sentiment Signal: Sell Current Market Cap: $232.8M